A compassionate use program of SM-88
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 22 Jan 2018
At a glance
- Drugs SM 88 (Primary)
- Indications Breast cancer; Colon cancer; Glioma; Lymphoma; Ovarian cancer; Pancreatic cancer; Prostate cancer; Sarcoma
- Focus Expanded access; Therapeutic Use
- 22 Jan 2018 New trial record
- 19 Jan 2018 According to a Tyme Technologies media release, results from patients (n=10) with pancreatic cancer from this or compassionate use program were presented in a poster presentation at the 2018 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium.
- 19 Jan 2018 Results from patients (n=10) with pancreatic cancer from this or compassionate use program presented in a Tyme Technologies media release.